Group 1 - The stock price of Zhendemedical (603301) closed at 70.39 yuan on February 4, 2026, with an increase of 2.07% and a turnover rate of 0.58% [1] - The trading volume was 15,500 shares, with a total transaction amount of 108 million yuan [1] - On February 4, the net inflow of main funds was 3.7659 million yuan, accounting for 3.5% of the total transaction amount [2] Group 2 - Zhendemedical announced a change in the project quality reviewer, with Wang Wen taking over from Zheng Chuanxian due to work adjustments [1] - Wang Wen has been a certified public accountant since 2011 and has been providing audit services to the company since 2025 [1] - The change in the quality reviewer will not affect the normal conduct of the company's 2025 financial statement and internal control audit [1]
股市必读:振德医疗(603301)2月4日主力资金净流入376.59万元,占总成交额3.5%